Mid-Year Report

RICCHETTI INCORPORATED for ELI LILLY AND COMPANY

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to the CHAMP Act (SCHIP reauthorization and Medicare reforms/offsets)

LobbyistCovered position, as disclosed
JEFF RICCHETTI N/A
STEVE RICCHETTI N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

issues pertaining to the importation of prescription drugs issues related to PDUFA (FDA Amendments Act, HR 2900 and S. 1082) issues related to MDUFA (FDA Amendments Act, HR 2900 and S. 1082) issues related to the Pharmaceutical Market Access and Safety Drug Act (S. 242, HR 380)

LobbyistCovered position, as disclosed
JEFF RICCHETTI N/A
STEVE RICCHETTI N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 242 (110th), S. 1082 (110th), H.R. 380 (110th), H.R. 2900 (110th)

Advertising ADV

issues relating to direct-to-consumer advertising of prescription drugs

LobbyistCovered position, as disclosed
JEFF RICCHETTI N/A
STEVE RICCHETTI N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

issues related to proposed reform of the US patent system (Patent Reform Act S. 1145, HR 1908)

LobbyistCovered position, as disclosed
JEFF RICCHETTI N/A
STEVE RICCHETTI N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.